7.19
Exagen Inc stock is traded at $7.19, with a volume of 129.07K.
It is down -2.44% in the last 24 hours and up +15.04% over the past month.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$7.37
Open:
$7.46
24h Volume:
129.07K
Relative Volume:
0.65
Market Cap:
$153.51M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-7.6489
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
+3.01%
1M Performance:
+15.04%
6M Performance:
+62.67%
1Y Performance:
+250.73%
Exagen Inc Stock (XGN) Company Profile
Name
Exagen Inc
Sector
Industry
Phone
(760) 560-1501
Address
1261 LIBERTY WAY, VISTA, CA
Compare XGN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
XGN
Exagen Inc
|
7.19 | 152.55M | 52.55M | -23.69M | -15.29M | -0.94 |
![]()
TMO
Thermo Fisher Scientific Inc
|
398.36 | 152.41B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
192.15 | 136.31B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
522.21 | 41.46B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
113.94 | 32.18B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
147.37 | 24.40B | 15.50B | 1.33B | 2.16B | 7.34 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-05-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Oct-15-21 | Resumed | Cowen | Outperform |
Apr-15-21 | Initiated | Canaccord Genuity | Buy |
Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
Oct-08-20 | Initiated | BTIG Research | Buy |
Jun-02-20 | Resumed | Cantor Fitzgerald | Overweight |
Oct-14-19 | Initiated | Cantor Fitzgerald | Overweight |
Oct-14-19 | Initiated | Cowen | Outperform |
Oct-14-19 | Initiated | William Blair | Outperform |
View All
Exagen Inc Stock (XGN) Latest News
Northern Trust Corp Has $75,000 Position in Exagen Inc. (NASDAQ:XGN) - Defense World
XGN Set to Participate in Virtual Meeting on June 11 | XGN Stock News - GuruFocus
Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World
Exagen stock soars to 52-week high, hits $7.2 amid robust gains By Investing.com - Investing.com South Africa
Exagen stock soars to 52-week high, hits $7.2 amid robust gains - Investing.com Nigeria
Research Analysts Issue Forecasts for Exagen FY2025 Earnings - Defense World
Exagen Inc.'s (NASDAQ:XGN) Shares Bounce 34% But Its Business Still Trails The Industry - simplywall.st
Cantor Fitzgerald Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - Defense World
Cantor Fitzgerald Reaffirms Their Buy Rating on Exagen (XGN) - The Globe and Mail
Exagen (XGN) Target Price Adjusted by Cantor Fitzgerald Followin - GuruFocus
Exagen (XGN) Price Target Lowered by Cantor Fitzgerald, Rating Maintained | XGN Stock News - GuruFocus
Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight By Investing.com - Investing.com Canada
Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight - Investing.com
Canaccord Genuity Group Forecasts Strong Price Appreciation for Exagen (NASDAQ:XGN) Stock - Defense World
Exagen (XGN) Maintains 'Buy' Rating as Price Target Rises | XGN Stock News - GuruFocus
Exagen (XGN) Receives Increased Price Target from Canaccord | XG - GuruFocus
Exagen (XGN) Receives Increased Price Target from Canaccord | XGN Stock News - GuruFocus
Exagen prices public offering of common stock - MSN
Exagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Exagen Inc. Announces Closing of $20.2 Million Public Offering I - GuruFocus
Exagen Inc. Announces Closing of $20.2 Million Public - GlobeNewswire
Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches - MSN
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares | XGN Stock News - GuruFocus
Exagen Inc. Completes Additional Public Offering of 502,500 Shares, Raising Approximately $20.2 Million - Nasdaq
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of ... - Bluefield Daily Telegraph
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares - Stock Titan
Earnings Update: Here's Why Analysts Just Lifted Their Exagen Inc. (NASDAQ:XGN) Price Target To US$7.75 - simplywall.st
Exagen Inc (XGN)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
Exagen sets price for public stock offering at $5.25 per share - Investing.com Nigeria
William Blair Issues Pessimistic Outlook for Exagen Earnings - Defense World
Exagen prices 3.35M shares at $5.25 per share in public offering - TipRanks
Exagen Prices $17.6 Million Public Offering; Shares Down - marketscreener.com
Exagen Inc. Prices Public Offering Of Common Stock At $5.25 Per Share - marketscreener.com
Exagen (XGN) Sets Price for Public Offering of Common Shares | XGN Stock News - GuruFocus
Exagen First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Exagen Inc. Prices Public Offering of Common Stock | XGN Stock News - GuruFocus
Exagen Inc. Prices Public Offering of Common Stock - Bluefield Daily Telegraph
William Blair Estimates Exagen’s Q1 Earnings (NASDAQ:XGN) - Defense World
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates - MSN
Exagen announces common stock offering, no amount given - TipRanks
Exagen (XGN) Announces Public Offering of Common Stock | XGN Stock News - GuruFocus
Exagen Inc. Announces Proposed Public Offering of Common Stock - The Manila Times
Exagen price target raised to $9 from $5 at BTIG - TipRanks
Exagen Inc Stock (XGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Exagen Inc Stock (XGN) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
NMSIC Co-Investment Fund, L.P. | 10% Owner |
Nov 20 '24 |
Sale |
3.30 |
200,000 |
660,040 |
2,108,958 |
Black Jeffrey G. | Chief Financial Officer |
Nov 15 '24 |
Buy |
2.98 |
22,298 |
66,448 |
274,492 |
ABALLI JOHN | President and CEO |
Nov 14 '24 |
Buy |
2.81 |
24,305 |
68,297 |
689,799 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):